Botaone 100 Units

Botaone 100UI

Botaone 100UI is designed for practitioners who want a standard clinic format without losing sight of the treatment objective. Built around botulinum toxin type A and human serum albumin, it is positioned for controlled treatment of expression-related lines, with its strongest practical fit linked to glabellar lines and crow’s feet.

The Product in Practice

A closer look at Botaone 100UI shows a product built around practical choices: what it contains, the type of correction it supports and how it differs from adjacent variants.

• Botaone 100UI formulation: botulinum toxin type A, human serum albumin, and sodium chloride
• Most relevant treatment areas: glabellar lines and crow’s feet
• Presentation details: 100 units, 0.1ml, and 2.5ml

1. Product and Unit Presentation

Botaone 100UI is positioned as standard 100-unit presentation for focused professional treatment planning. The relationship between its formulation, strength, presentation and professional objective defines this exact product more clearly than its category name alone.

2. Neuromuscular Action

Botaone 100UI works through botulinum toxin type A, which temporarily limits acetylcholine-mediated signalling between nerves and selected muscles. In professional aesthetic use, this controlled reduction in muscle activity can soften expression-related lines while allowing the treatment plan to be adapted to the area, muscle strength and desired degree of movement.

3. Aesthetic Treatment Objectives

• Softening dynamic expression lines
• Smoother-looking facial lines

4. Common Professional Applications

Botaone 100UI is commonly associated with:

• Glabellar lines
• Crow’s feet
• Lips and perioral area
• Nasolabial folds
• Neck

The practitioner determines whether Botaone 100UI fits the selected area, tissue plane and treatment objective.

5. Composition and Vial Specifications

The formulation includes botulinum toxin type A, human serum albumin, and sodium chloride. The sealed label for Botaone 100UI remains the controlling reference for its exact ingredient statement.

• Product: Botaone 100UI
• Product type: Botulinum toxin type A product
• Botaone 100UI: Variant profile: Standard 100-unit presentation for focused professional treatment planning
• Reported strength or volume: 100UI
• Botaone 100UI: Reported formulation: botulinum toxin type A, human serum albumin, and sodium chloride
• Package details: single vial and lyophilized powder
• Storage profile: refrigerated at 2°C to 8°C and do not freeze

6. Onset and Duration Profile

For Botaone 100UI, a duration of approximately 6 months is reported. Timing can vary with the treatment area, technique, quantity used and individual response, so the product should be evaluated by the progression and quality of the result rather than by one fixed timetable.

7. Reconstitution, Storage and Handling

For this formulation, the reported package presentation includes single vial and lyophilized powder. The available product information specifies refrigerated at 2°C to 8°C and do not freeze. The sealed outer box and current instructions remain the controlling handling reference.

8. Choosing the Correct Strength

For Botaone 100UI, this formulation must remain separate from other strengths in the same toxin family. A 50U, 100U, 200U or 300U presentation changes the total units available in the vial; it does not create an automatic one-to-one treatment plan, because dosing remains product- and practitioner-specific. The exact unit presentation should therefore be selected according to the intended professional use.

9. Frequently Asked Questions

What is Botaone 100UI?

For Botaone 100UI, this presentation is a botulinum toxin type A product positioned as standard 100-unit presentation for focused professional treatment planning. Its page is built around the exact formulation and presentation rather than a generic description of the category.

What is the main purpose of Botaone 100UI?

For Botaone 100UI, for this formulation, its product profile centres on softening dynamic expression lines and smoother-looking facial lines. The final treatment objective and technique are selected by a qualified professional.

What does Botaone 100UI contain?

For Botaone 100UI, for the named variant, available product information describes botulinum toxin type A, human serum albumin, and sodium chloride.

Which areas are associated with Botaone 100UI?

The product information associates the product with glabellar lines, crow’s feet, lips and perioral area, nasolabial folds, and neck. Suitability and placement depend on the exact product instructions and individual assessment.

How is Botaone 100UI supplied?

For Botaone 100UI, the product is described with single vial and lyophilized powder. Current outer-box information remains the controlling reference for the received market presentation.

What makes this exact version different?

For Botaone 100UI, the named variant must remain separate from other strengths in the same toxin family. A 50U, 100U, 200U or 300U presentation changes the total units available in the vial; it does not create an automatic one-to-one treatment plan, because dosing remains product- and practitioner-specific. The exact unit presentation should therefore be selected according to the intended professional use.